Nombre del producto:tetrasodium;5-[[[(1S)-1-(4-bromophenyl)ethyl]amino]-phosphonatomethyl]quinoxaline-2,3-diolate

IUPAC Name:tetrasodium 5-({[(1S)-1-(4-bromophenyl)ethyl]amino}(phosphonato)methyl)quinoxaline-2,3-bis(olate)

CAS:2102348-87-6
Fórmula molecular:C17H13BrN3Na4O5P
Pureza:95%+
Número de catálogo:CM674053
Peso molecular:542.14

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2102348-87-6
Fórmula molecular:C17H13BrN3Na4O5P
Punto de fusión:-
Código de sonrisas:[Na+].[Na+].[Na+].[Na+].C[C@H](NC(C1=CC=CC2=NC([O-])=C([O-])N=C12)P([O-])([O-])=O)C1=CC=C(Br)C=C1
Densidad:
Número de catálogo:CM674053
Peso molecular:542.14
Punto de ebullición:
Nº Mdl:MFCD08705420
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.